The global market for southern blotting is expected to grow at a CAGR of 4.88% from 2024 to 2029. The market size is anticipated to be worth USD 3.01 billion by 2029 from USD 2.37 billion in 2024.
A blotting technique in molecular biology is defined as a transfer of electrophoresed samples of DNA, RNA, and proteins onto a suitable carrier such as nylon or nitrocellulose membrane and polyvinylidene difluoride (PVDF) membrane and subsequent fragment detection by probe hybridization. Southern blotting is a molecular biology technique to detect specific DNA sequences in DNA samples.
Other factors contributing to the growth of the global southern blotting market are the rising incidence of diseases such as congenital adrenal hyperplasia and HIV-1 and the demand for faster diagnosis. In addition, the increasing use of southern blotting procedures in medical diagnostics and forensic science applications are other key factors responsible for driving the global southern blotting market.In addition, the growing focus on developing new drugs in high-quality pharmaceutical companies is ascribed to bolstering the growth rate of the southern blotting market. Furthermore, the prevalence of effective treatment procedures for genetic disorders among individuals also favors the market. Southern blotting instruments are essential in DNA fragments and molecular R&D and are very accurate in detecting various chronic diseases.Ongoing research and development on manufacturing innovative products in favor of the end-users fuel the growth of this market. In addition, the rise in the demand for medical tourism and increased spending on the construction of hospitals with the latest equipment are elevating the growth rate of the southern blotting market. Furthermore, the emergence of advanced technology in developing drugs for various genetic disorders creates growth opportunities for the market. The rise in the incidences of chronic diseases is also greatly influencing the demand for the southern blotting market. Growing support from government organizations through investments in hospitals and clinics and rapid adoption of southern blotting instruments and consumables in the medical sector by knowing its benefits are further leveraging the growth rate of the southern blotting market.
However, factors such as the non-availability of the device in developing countries and the emergence of alternative technologies, inadequate funding in developing countries, and high pricing of products are expected to hamper overall market growth for the global southern blotting market.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Product, End User, Application, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa |
Market Leaders Profiled |
Agilent Technologies, ThermoFisher Scientific, Applied Biosystems, Aplegan |
Based on the product, the Instruments segment is anticipated to be the attractive segment driving massive revenue for market players. The factor that is helping the segment's dominance is the widespread use of southern blotting instruments in various fields like research and healthcare. However, the kits and reagents segment is also expected to show healthy growth in the market as there is rising interest in research in southern blotting techniques in pharmaceutical and biotechnology companies.
Based on the end-user, the pharmaceuticals and biotechnology industry segment is expected to dominate the market during the forecast period due to the rising critical players in the industry and growing research and development among competitors.Additionally, the contract research organizations are expected to show growth during the forecast period due to the rising preference toward third-party organizations' assistance with approvals for clinical trials due to stringent rules and regulations from the FDA.
Based on application, the scientific research segment commands a significant market share during the forecast period. As the southern blotting techniques are heavily used in the studies of life sciences like proteomics and genomics, the segment is expected to hold a significant market share. Moreover, many additional genomic assays are used in blotting techniques for research purposes supporting the market's growth. But still, it is likely to lose considerable market to the medical diagnosis category because of the increasing applications of southern blotting in the healthcare industry. Moreover, better ways of disease diagnostics are being researched through the biosciences field, further promoting the segment's expansion.
North America held a significant share of the global southern blotting market in 2023 due to a dramatic rise in HIV-1 prevalence, increasing production of genetically modified crops, rising government funding, and increased spending on research and development procedures. Additionally, crucial biotechnology and clinical research companies in countries like the U.S. and Canada drive the market's growth. Furthermore, the availability of advanced infrastructures and availability of assays is driving growth.
Europe commands the second position in the market because of the adoption of advanced technology in this region's biotechnology and research sector. Countries like the U.K., Italy, France, and Germany are leading players in life science research, leading to more revenue for the market. Additionally, increasing interest in proteomics and genomics studies is pushing clinical research and development in the region, augmenting growth.
Asia is anticipated to experience high growth rates for the southern blotting market in the forecast period due to the growing incidence of HIV infections, increasing biotechnological and pharmaceutical industries in this region, the vast pool of aging population with different diseases indications and increasing expenditure by several governments on healthcare. In addition, the significant development of the emerging economies of India and China will also lead to the growth of this region.
A few of the major companies dominating the global southern blotting market profiled in this report are Agilent Technologies, ThermoFisher Scientific, Applied Biosystems, Aplegan, BioRad Laboratories, Perkin Elmer Inc., Cleaver Scientific Ltd, and Pall Life Science Laboratories.
In November 2022, the annual American Society of Human Genetics meeting featured the research and revenue reports from Bionano genomics, a life sciences company. The company brought forth 50+ researchers and scientists to present the data about how OGM is a technique that can revolutionize molecular and cytogenetic research and its utility in genetic disease research. In addition, the company announced its third-quarter financial reports and data presentation.
In June 2022, during the 70th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics, Thermofisher scientific solutions announced the new research and development in vaccine and therapy studies. In addition, the company presented its latest mass spectrometry instruments and new gen analytical insights in spectrometry.
This research report on the global southern blotting market has been segmented and sub-segmented based on the product, end-user, application, and region.
By Product
Instruments
By End User
By Application
By Region
Frequently Asked Questions
The global southern blotting market size was valued at USD 2.37 billion in 2024.
Agilent Technologies, ThermoFisher Scientific, Applied Bio systems, Aplegan, BioRad Laboratories, Perkin Elmer Inc., Cleaver Scinetific Ltd, and Pall Life Science Laboratories are some of the key players in the southern blotting market.
In Europe, the southern blotting market is anticipated to grow at a CAGR of 4.07% from 2024 to 2029.
Geographically, the North American region accounted for a major share of the market in 2023.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region